An overview of the interferon system: Signal transduction and mechanisms of action

Cancer Investigation

Volumn 14, Issue 1, 1996, Pages 25-53

  Kalvakolanu, Dhananjaya V ^a   Borden, Ernest C ^a  

^a UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; GAMMA INTERFERON; INTERFERON RECEPTOR; TAU INTERFERON;

GENETIC REGULATION; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 0029887863     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357909609018435     Document Type: Review

References (348)

1. DeMaeyer E, DeMaeyer-Guignard J, eds: Interferons and Other Regulatory Cytokines, New York, Wiley Interscience, 1988.
2. Isaacs A, Lindenmann J: Viral interference. I. The Interferon. Proc R Soc Lond B Biol Sci 147:258-267, 1957.
3. Pestka S, Langer J, Zoon K, et al: Interferons and their actions. Annu Rev Biochem 56:727-777, 1987.
4. Gresser I: Antitumor effects of interferons: Past, present, and future. Br J Haematol 79:1-5, 1991.
5. Samuel C: Antiviral actions of interferon: Interferon-regulated proteins and their surprisingly selective antiviral activities. Virology 183:1-11, 1991.
6. Borden EC: Interferons. In: Cancer Medicine, edited by JF Holland, EF Frei III, RC Bast, DW Kufe, DL Morton, RR Weichselbaum, Philadelphia, Lea & Febiger, 1993, pp 927-936.
7. Sen GC, Ransohoff RM: Interferon-induced antiviral actions and their regulation. Adv Virus Res 42:57-101, 1993.
8. Haines DS, Strauss KI, Gillespie DH: Cellular response to double stranded RNA. J Cell Biochem 46:9-20, 1991.
9. Reis LF, Ho LT, Vilcek J: Tumor necrosis factor acts synergistically with autocrine interferon-beta and increases interferon-beta mRNA levels in human fibroblasts. J Biol Chem 264:16351-16354, 1989.
10. Marcus P, Sekellick M: Defective interfering particles with covalently linked [±] RNA induce interferon. Nature 266:815-819, 1977.
11. Diaz MO, Bohlander S, Allen G: Nomenclature of human interferon genes. J Interferon Res 13:234-243, 1993.
12. Harada H, Willison K, Sakakibara J, et al: Absence of the type I IFN system in EC cells: Transcriptional activator (IRF-1) and repressor (IRF-2) genes are developmentally regulated. Cell 63:303-312, 1990.
13. Ringold G, Dieckmann B, Vannice J: Inhibition of protein synthesis stimulates the transcription of human beta-interferon gene in Chinese hamster ovary cells. Proc Natl Acad Sci USA 81:3964-3968, 1984.
14. Dinter H, Hauser H: Superinduction of the human interferon-β promoter. EMBO J 6:599-604, 1987.
15. Steward WE II, Gosser LB, Lockart RZ Jr: The effect of priming with interferon on interferon production by two lines of L cells. J Gen Virol 15:85-87, 1972.
16. Tanaka N, Taniguchi T: Cytokine gene regulation: Regulatory cis elements and DNA binding factors involved in the interferon system. Adv Immunol 52:263-281, 1992.
17. Goodbourn S, Maniatis T: Overlapping positive and negative regulatory domains of the human β-interferon gene. Proc Natl Acad Sci USA 85:1447-1451, 1988.
18. Fujita T, Shibuya H, Hotta H, et al: Interferon-β gene regulation: Tandemly repeated sequences of a synthetic 6 bp oligomer function as a virus-inducible enhancer. Cell 49:357-367, 1987.
19. Kuhl D, de la Fuente J, Chaturvedi M, et al: Reversible silencing of enhancers by sequences derived from the human IFN-α promoter. Cell 50:1057-1069, 1987.
20. Fujita T, Kimura Y, Miyamoto M, et al: Induction of endogenous IFN-α and IFN-β genes by a regulatory transcription factor, IRF-1. Nature 337:270-272, 1989.
21. Harada H, Fujita T, Miyamoto M, et al: Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell 58:729-739, 1989.
22. Watanabe N, Sakakibara J, Hovanessian A, et al: Activation of IFN-element by IRF-1 requires a post-translational event in addition to IRF-1 synthesis. Nucleic Acid Res 19:4421-4428, 1991.
23. Palombella VJ, Maniatis T: Inducible processing of interferon regulatory factor-2. Mol Cell Biol 12:3325-3336, 1992.
24. Sims SH, Cha Y, Romine MF, et al: A novel interferon-inducible domain: Structural and functional analysis of the human interferon regulatory factor 1 gene promoter. Mol Cell Biol 13:690-702, 1993.
25. Yamada G, Ogawa M, Akagi K, et al: Specific depletion of the B-cell population induced by aberrant expression of human interferon regulatory factor 1 gene in transgenic mice. Proc Natl Acad Sci USA 88:532-536, 1991.
26. Watanabe N, Sakakibara J, Taniguchi T, et al: Identification and characterization of a novel DNA binding factor v-IRF-1, a candidate activator of the IFN-β gene. J Interferon Res 13:(Suppl 1)S177, 1993.
27. Fujita T, Reis L, Watanabe N, et al: Induction of the transcription factor IRF-1 and interferon-β mRNAs by cytokines and activators of second-messenger pathways. Proc Natl Acad Sci USA 86: 9936-9340, 1989.
28. Keller A, Maniatis T: Identification and characterization of a novel repressor of β-interferon gene expression. Genes Dev 5:868-879, 1991.
29. Fujita T, Miyamoto M, Kimura Y, et al: Involvement of a cis-element that binds an H2TF-1/NF-κB like factor(s) in the virus-induced interferon-beta gene expression. Nucleic Acids Res 17: 3335-3347, 1989.
30. Lenardo M, Fan C, Maniatis T, et al: The involvement of NF-κB in beta-interferon gene regulation reveals its role as widely inducible mediator of signal transduction. Cell 57:287-294, 1989.
31. Viswanathan K, Goodbourn S: Double-stranded RNA activates binding of NF-κB to an inducible element in the human β-interferon promoter. EMBO J 8:1129-1138, 1989.
32. Baeuerle P, Baltimore D: The physiology of the NF-κB transcription factor. In: The Hormonal Control of Gene Expression, edited by P Cohen, JG Foulkes, Amsterdam, Elsevier, 1991, pp 423-446.
33. Beg AA, Baldwin AS Jr: The IκB-proteins: Multifunctional regulators of rel/NF-κB transcription factors. Genes Dev 7:2064-2070, 1993.
34. Blank V, Kourilsky P, Israel A: NF-κB and related proteins: Rel/dorsal homologies meet ankyrin-like repeats. Trends Biochem Sci 17:135-140, 1992.
35. Havell E, Hayes T, Vilcek J: Synthesis of two distinct interferons by human fibroblasts. Virology 89:330-334, 1978.
36. Ryals J, Dierks P, Ragg H, et al: A 46-nucleotide promoter segment from an IFN-α gene renders unrelated promoter inducible by virus. Cell 41:497-507, 1985.
37. MacDonald N, Kuhl D, Maguire D, et al: Different pathways mediate virus inducibility of the human IFN-α1 and IFN-β genes. Cell 60:767-779, 1990.
38. Au W-C, Raj NBK, Pine R, et al: Distinct activation of murine interferon-promoter region by IRF-1/ISGF-2 and virus infection. Nucleic Acids Res 20:1531-1538, 1992.
39. Raj N, Au W-C, Pitha P: Identification of a novel virus-responsive sequence in the promoter of murine interferon-α genes. J Biol Chem 266:11360-11365, 1991.
40. Heron I, Hokland M, Berg K: 13 native interferons-alpha species assessed for immunoregulatory properties. J Interferon Res 3:231-239, 1983.
41. Young HA, Hardy KJ: Interferon-gamma: Producer cells, activation stimuli, and molecular genetic regulation. Pharm Ther 45: 137-151, 1990.
42. Pang Y, Norihisa Y, Benjamin D, et al: Interferon-gamma gene expression in human B-cell lines: Induction by interleukin-2, protein kinase C activators, and possible effect of hypomethylation on gene regulation. Blood 80:724-32, 1992.
43. Hardy KJ, Young HA: IFN-gamma: Gene structure and regulation. In: Interferons: Principles and Medical Application, edited by S Baron, DH Coppenhaver, F Dianzani, Galveston, University of Texas Medical Branch Press, 1992, pp 47-64.
44. Farrar WL, Birchenall SM, Young HB: Interleukin-2 induction of interferon-gamma mRNA synthesis. J Immunol 137:3836-3840, 1986.
45. Chan SH, Kobayashi M, Santoli D, et al: Mechanisms of IFN-gamma induction by natural killer cell stimulatory factor (NKSF/ IL-12): Role of transcription and mRNA stability in the synergistic interaction between NKSF and IL-2. J Immunol 148:92-98, 1992.
46. Recht M, Borden EC, Knight E Jr: A human 15-kDa IFN-induced protein induces the secretion of IFN-gamma. J Immunol 147: 2617-2623, 1991.
47. Ciccarone VC, Chrivia J, Hardy KJ, et al: Identification of enhancer-like elements in human IFN-gamma genomic DNA. J Immunol 144:725-730, 1990.
48. Sica A, Tan T-H, Rice N, et al: The c-rel protooncogene product c-rel but not NF-κB binds to the intronic region of the human interferon-gamma gene at a site related to an interferon-stimulable response element. Proc Natl Acad Sci USA 89:1740-1744, 1992.
49. Brown DA, Kondo KL, Wong SW, et al: Characterization of nuclear protein binding to the interferon-gamma promoter in quiescent and activated human T cells. Eur J Immunol 22:2419-2428, 1992.
50. Brown DA, Nelson FB, Reinherz EL, et al: The human interferon-gamma gene contains an inducible promoter than can be transactivated by tax I and II. Eur J Immunol 21:1879-1885, 1991.
51. Cross J, Roberts R: Constitutive and trophoblast-specific expression of a class of bovine interferon genes. Proc Natl Acad Sci USA 88:3817-3821, 1991.
52. Roberts RM, Cross JC, Leaman DW: Unique features of the trophoblast interferons. Pharm Ther 51:329-45, 1991.
53. Aguet M: Molecular cloning of interferon receptors: A short review. Br J Haematol 79:6-8, 1991.
54. Mariano TM, Donnelly RJ, Son J, et al: Structure and function of the type I interferon receptor. In: Interferon: Principles and Medical Applications, edited by S Baron, DH Coppenhaver, F Dianzani, et al. Galveston, University of Texas Medical Branch, 1992, pp 129-138.
55. Stuber D, Fountoulakis M, Garrotta G: IFN-receptor: Protein structure and function. In: Interferon: Principles and Medical Application, edited by S Baron, DH Coppenhaver, F Dianzani, et al. Galveston, University of Texas Medical Branch, 1992, pp 139-150.
56. Uze G, Lutfalla G, Gresser I: Genetic transfer of a functional human interferon-α receptor into mouse cells: Cloning and expression of its cDNA. Cell 60:225-234, 1990.
57. Lutfalla G, Gardinar L, Proudhon D, et al: The structure of the human interferon-α/β receptor gene. J Biol Chem 267:2802-2809, 1992.
58. Colamonici OR, Domanski P: Identification of a novel subunit of the type I Interferon receptor localized to human chromosome 21. J Biol Chem 268:10895-10899, 1993.
59. Platanias LC, Colamonici OR: Interferon alpha induces rapid tyrosine phosphorylation of the alpha subunit of its receptor. J Biol Chem 267:24053-24057, 1992.
60. tyk2, an interferon-α-activated tyrosine kinase, is physically associated with an interferon-α receptor. J Biol Chem 269:3518-3522, 1994.
61. Delcayre S, Salas F, Mathur S, et al: Epstein Barr virus/complement C3d receptor is an interferon-α receptor. EMBO J 10:919-926, 1991.
62. Aguet M, Dembic Z, Merlin G: Molecular cloning and expression of the human interferon-gamma receptor. Cell 55:273-280, 1988.
63. Gray P, Leong S, Fennie E, et al: Cloning and expression of the cDNA for the murine interferon-gamma receptor. Proc Natl Acad Sci USA 86:8479-8501, 1989.
64. Hemmi S, Peghini P, Merlin G, et al: Cloning of murine interferon-gamma receptor cDNA: Expression in human cells mediates high-affinity binding but is not sufficient to confer sensitivity to murine interferon-gamma. Proc Natl Acad Sci USA 86:9901-9905, 1989.
65. Munro S, Maniatis T: Expression cloning of the murine interferon-gamma receptor cDNA. Proc Natl Acad Sci USA 86:9248-9252, 1989.
66. Jung V, Rashidbaigi A, Jones C, et al: Human chromosome 6 and 21 are required for sensitivity to human Interferon. Proc Natl Acad Sci USA 84:4151-4155, 1987.
67. Hibino Y, Kumar C, Mariano T, et al: Chinieric interferon-gamma receptors demonstrate that an accessory factor required for activity interacts with the extracellular domain. J Biol Chem 267:3741-3749, 1992.
68. Hemmi S, Merlin G, Aguet M: Functional characterization of a hybrid human-mouse interferon gamma receptor: Evidence for species-specific interaction of the extracellular receptor domain with a putative signal transducer. Proc Natl Acad Sci USA 89:2737-2741, 1992.
69. Hershey G, McCourt D, Schreiber R: Ligand-induced phosphorylation of the human interferon-gamma receptor. J Biol Chem 265:17865-17868, 1990.
70. Greenlund AC, Farrar MA, Viviano BL et al: Ligand induced IFN-γ receptor tyrosine phosphorylation couples the receptor to its signal transduction sytem (p91). EMBO J 13: 1591-1600, 1994.
71. Huang S, Hendriks W, Althage A, et al: Immune response in mice that lack the interferon-gamma receptor. Science 259:1742-1745, 1993.
72. Branca A, Faltyneck C, D'Alessandro S, et al: Interaction of interferon with cellular receptors: Internalization and degradation of cell-bound interferon. J Biol Chem 257:13291-13296, 1982.
73. Pellegrini S, SchindlerC: Early events in signalling by interferons. Trends Biochem Sci 18:338-342, 1993.
74. Friedman R, Manly S, McMahon M, et al: Transcriptional and posttranscriptional regulation of interferon-induced gene expression in human cells. Cell 38:745-755, 1984.
75. Hannigan G, Williams B: Transcriptional regulation of interferon-responsive genes is closely linked to Interferon receptor occupancy. EMBO J 5:1607-1613, 1986.
76. Tiwari RK, Kusari J, Kumar R, et al: Gene induction by interferons and double-stranded RNA: Selective inhibition by 2-aminopurine. Mol Cell Biol 8:4289-4294, 1988.
77. Bandyopadhyay SK, Kalvakolanu DVR, Sen GC: Gene induction by interferons: Functional complementation of trans-acting factors induced by α-interferon and gamma-interferon. Mol Cell Biol 10:5055-5063, 1990.
78. Kessler DS, Levy DE: Protein kinase activity required for an early step in interferon-signaling. J Biol Chem 266:23417-23476, 1991.
79. Pfeffer LM, Eisenkraft BL, Reich NC, et al: Transmembrane signaling by interferon alpha involves diacylglycerol production and activation of the epsilon isoform of protein kinase C in Daudi cells. Proc Natl Acad Sci USA 88:7988-7992, 1991.
80. Bandyopadhyay SK, Sen GC: Role of protein phosphorylation in activation of interferon-α stimulated gene factors. J Biol Chem 267:6389-6395, 1992.
81. Wang C, Constantinescu SN, MacEwan DJ, et al: Interferon-α induces protein kinase C-ε (PKC-ε) gene expression and a 4.7-kb PKC-ε-related transcript. Proc Natl Acad Sci USA 90:6944-6948, 1993.
82. Stark GR, Kerr IM: Interferon-dependent signaling pathways: DNA elements, transcription factors, mutations, and effects of viral proteins. J Interferon Res 12:147-151, 1992.
83. Hannigan G, Williams B: Signal transduction by interferon-α through arachidonic acid metabolism. Science 251:204-207, 1991.
84. 83a. Kalvakolanu DV, Mannino SB, Thornton A, et al: Transcriptional induction of genes by IFN-b in mouse cells is regulated by a transcription factor similar to human ISGF-3. Antiviral Res 25: 91-103, 1994.
85. Gutch MJ, Daly C, Reich NC: Tyrosine phosphorylation is required for activation of an interferon-α stimulated transcription factor. Proc Natl Acad Sci USA 89:11411-11415, 1992.
86. Schindler C, Shuai K, Prezioso VR, et al: Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor. Science 257:809-812, 1992.
87. Fu X-Y: A transcriptional factor with SH2 and SH3 domains is directly activated by an interferon α-induced cytoplasmic protein tyrosine kinase(s). Cell 70:323-335, 1992.
88. Pawson T, Gish GD: SH2 and SH3 domains: From structure to function. Cell 71:359-362, 1992.
89. David M, Larner AC: Activation of transcription factors by interferon-alpha in a cell-free system. Science 257:813-815, 1992.
90. Velazquez L, Fellous M, Stark GR, et al: A protein tyrosine kinase in the interferon α/β signaling pathway. Cell 70:313-322, 1992.
91. Muller M, Briscoe J, Laxton C, et al: The protein tyrosine kinase JAK1 complements defects in interferon-alpha/beta and gamma signal transduction. Nature 366:129-135, 1993.
92. Waiting D, Guschin D, Muller M, et al: Complementation by the protein tyrosine kinase JAK-2 of a mutant cell line defective in the interferon-gamma signal transduction pathway. Nature 366:166-170, 1993.
93. Silvennoinen O, Ihle JN, Schlessinger J, et al: Interferon-induced nuclear signaling by Jak protein tyrosine kinases. Nature 366:583-585, 1993.
94. Shuai K, Ziemiecki A, Wilks AF, et al: Polypeptide signalling to the nucleus through tyrosine phosphorylation of Jak and Stat proteins. Nature 366:580-583, 1993.
95. David M, Grimely PM, Finbloom DS, et al: A nuclear tyrosine phosphatase downregulates interferon-induced gene expression. Mol Cell Biol 13:5715-5721, 1993.
96. Friedman R, Stark G: Alpha-interferon-induced transcription of HLA and metallothionein genes containing homologous upstream sequences. Nature 314:637-639, 1985.
97. Reid L, Brasnett A, Gilbert C, et al: A single DNA response element can confer inducibility by both α- and γ-interferons. Proc Natl Acad Sci USA 86:840-844, 1989.
98. Reich N, Evans B, Levy D, et al: Interferon-induced transcription of a gene encoding a 15-kDa protein depends on an upstream enhancer element. Proc Natl Acad Sci USA 84:6394-6398, 1987.
99. Levy D, Kessler D, Pine R, et al: Interferon-induced nuclear factors that bind a shared promoter element correlate with positive and negative transcriptional control. Genes Dev 2:383-393, 1988.
100. Porter A, Chernajovsky Y, Dale T, et al: Interferon response element of the human gene 6-16. EMBO J 7:85-92, 1988.
101. Dale T, Rosen J, Guille M, et al: Overlapping sites for constitutive and induced DNA-binding factors involved in interferon-α stimulated transcription. EMBO J 8:831-839, 1989a.
102. Wathelet MG, Clauss IM, Content J, et al: Regulation of two interferon-inducible human genes by Interferon, ploy (rI).poly(rC) and viruses. Eur J Biochem 174:323-329, 1988.
103. Daly C, Reich NC: Double-stranded RNA activates novel factors that bind to the interferon-stimulated response element. Mol Cell Biol 13:3756-3764, 1993.
104. Pine R, Canova A, Schindler C: Tyrosine phosphorylated p91 binds to single element in the ISGF2/IRF-1 promoter to mediate induction by IFNα and IFNγ, and is likely to autoregulate the p91 gene. EMBO J 13:158-167, 1994.
105. Kanno Y, Kozak CA, Schindler C, et al: The genomic structure of the murine ICSBP gene reveals the presence of the gamma interferon-responsive element, to which an ISGF3 subunit (or similar) molecule binds. Mol Cell Biol 13:3951-3963, 1993.
106. Decker T, Lew D, Mirkovitch J, et al: Cytoplasmic activation of GAF, an IFN-γ-regulated DNA-binding factor. EMBO J 10:927-932, 1991.
107. Lew DJ, Decker T, Strehlow I, et al; Overlapping elements in the guanylate-binding protein gene promoter mediate transcriptional induction by alpha and gamma interferons. Mol Cell Biol 11:182-191, 1991.
108. Khan KD, Shuai K, Lindwall G, et al: Induction of the Ly-6E/A gene by interferon alpha/beta and gamma requires a DNA element to which a tyrosine-phosphorylated 91-kDa protein binds. Proc Natl Acad Sci USA 90:6806-6810, 1993.
109. Khan K, Lindwall G, Maher SE, et al: Characterization of promoterelements of an interferon-inducible Ly-6E/A differentiation antigen, which is expressed on activated T cells and hematopoietic stem cells. Mol Cell Biol 10:5150-5159, 1990.
110. Boss J, Stominger J: Regulation of a transfected human class II major histocompatibility complex gene in human fibroblasts Proc Natl Acad Sci USA 83:9139-9143, 1986.
111. Basta P, Sherman P, Ting JP-Y: Detailed delineation of an interferon-γ-responsive element important in human HLA-DR gene expression in a glioblastoma multiforme line. Proc Natl Acad Sci USA 85:8618-3622, 1988.
112. Thanos D, Mavrothalassitis G, Papamatheakis J: Multiple regulatory regions on the 5′ side of the mouse Eα gene. Proc Natl Acad Sci USA 85:3075-3079, 1988.
113. Dedrick R, Jones P: Sequence elements required for activity of a murine major histocompatibility complex class II promoter bind common and cell-type-specific nuclear factors. Mol Cell Biol 10:593-604, 1990.
114. Tsang S, Nakanishi M, Peterlin B: Mutational analysis of the DRA promoter: cis-acting sequences and trans-acting factors. Mol Cell Biol 10:711-719, 1990.
115. Brown A, Barr C, Ting J-Y: Sequences homologous to class II MHC W, X, and Y elements mediate constitutive and IFN-gamma-induced expression of human class II associated invariant chain. J Immunol 146:3183-3189, 1991.
116. Pearse RN, Reinman R, Ravetch JV: Characterization of the promoter of the human gene encoding the high-affinity IgG receptor: Transcriptional induction by γ-interferon is mediated through common DNA response elements. Proc Natl Acad Sci USA 88:11305-11309, 1991.
117. Pearse RN, Reinman R, Shuai K, et al: Interferon gamma-induced transcription of the high-affinity Fc receptor for IgG requires assembly of a complex that includes the 91-kDa subunit of transcription factor ISGF3. Proc Natl Acad Sci USA 90:4314-4318, 1993.
118. McKendry R, John J, Flavell D, et al: High-frequency mutagenesis of human cells and characterization of a mutant unresponsive to both alpha and gamma interferons. Proc Natl Acad Sci USA 88:11455-11459, 1991.
119. Yang Z, Sugawara M, Ponath P, et al: Interferon-γ response region in the promoter of the human DPA gene. Proc Natl Acad Sci USA 87:9226-9230, 1990.
120. Bonni A, Frank DA, Schindler C, et al: Characterization of a pathway for ciliary neurotrophic factor signaling to the nucleus. Science 262:1575-1579, 1993.
121. Fu X-Y, Zhang J-J: Transcription factor p91 interacts with the epidermal growth factor receptor and mediates activation of c-fos gene promoter. Cell 74:1135-1145, 1993.
122. Larner AC, David M, Feldman GM, et al: Tyrosine phosphorylation of DNA binding proteins by multiple cytokines. Science 261:1730-1732, 1993.
123. Sodowski HB, Shuai K, Darnell JR JE, et al: A common nuclear signal transduction pathway activated by growth factor and cytokine receptors. Science 261:1739-1744, 1993.
124. Silvennoinen O, Schindler C, Schlessinger J, et al: ras-independent growth factor signaling by transcription factor tyrosine phosphorylation. Science 261:1736-1739, 1993.
125. Wegenka UM, Buschmann J, Lutticken C, et al: Acute-phase response factor, a nuclear factor binding to acute-phase response elements, is rapidly activated by interleukin-6 at the posttranslational level. Mol Cell Biol 13:276-288, 1993.
126. Schmitt-Ney M, Happ B, Ball RK, et al: Developmental and environmental regulation of a mammary gland specific transcription factor essential for transcription of the gene encoding betacasein. Proc Natl Acad Sci USA 89:3130-3134, 1992.
127. Yu-Lee L-Y, Hrachovy J, Stevens A, et al: Interferon-regulatory factor 1 is an immediate-early gene under transcriptional regulation by prolactin in Nb2 T cells. Mol Cell Biol 10:3087-3094, 1991.
128. Schwarz LA, Stevens AM, Hrachovy JA, et al: Interferon regulatory factor-1 is inducible by prolactin, interleukin-2, and concanavalin AmT cells. Mol Cell Endocrinol 86:103-110, 1992
129. Cohen B, Peretz D, Vaiman D, et al: Enhancer-like interferon responsive sequences of the human murine (2′-5′) oligoadenylate synthetase gene promoters. EMBO J 7:1411-1419, 1998.
130. Kessler D, Levy D, Darnell JE Jr: Two interferon-induced nuclear factors bind a single promoter element in interferon-stimulated genes. Proc Natl Acad Sci USA 85:8521-8525, 1988.
131. Rutherford MN, Hannigan GE, Williams BRG: Interferon-induced binding of nuclear factors to promoter elements of the 2-5 A synthetase gene. EMBO J 7:751-759, 1988.
132. Imam A, Ackrill A, Dale T, et al: Transcription factors induced by interferons-α and -γ. Nucleic Acids Res 18:6573-6580, 1990.
133. Pine R, Decker T, Kessler DS, et al: Purification and cloning of interferon-stimulated gene factor 2 (ISGF2): ISGK2 (IRF-1) can bind to the promoters of both β interferon- and interferon-stimulated genes but is not a primary transcriptional activator of either. Mol Cell Biol 10:2448-2457, 1990.
134. Reis LF, Harada H, Wolchok JD, et al: Critical role of a common transcription factor, IRF-1, in the regulation of IFN-beta and IFN-inducible genes. EMBOJ 11:185-193, 1992.
135. Matsuyama T, Kimur T, Kitagawa M, et al: Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN-gene induction and aberrant lymphocyte development. Cell 75:83-97, 1993.
136. Ruffner H, Reis LFL, Naf D, et al: Induction of type I interferon genes and interferon-inducible genes in embryonal stem cells devoid of interferon regulatory factor 1. Proc Natl Acad Sci USA 90:11503-11507, 1993.
137. Levy DE, Kessler DS, Pine R, et al: Cytoplasmic activation of ISGF3, the positive regulator of interferon-α-stimulated transcription, reconstituted in vitro. Genes Dev 3:1362-1371, 1989.
138. Dale T, Imam A, Kerr I, et al: Rapid activation by interferon-α of a latent DNA-binding protein present in the cytoplasm of untreated cells. Proc Natl Acad Sci USA 86:1203-1207, 1989.
139. Fu X-Y, Kessler DS, Veals SA, et al: ISGF3, the transcriptional activator induced by interferon-α, consists of multiple interacting polypeptide chains. Proc Natl Acad Sci USA 87:8555-8559, 1990.
140. Kessler DS, Veals SA, Fu X-Y, et al: Interferon-α regulated nuclear translocation and DNA-binding affinity of ISGF3, a multimeric transcriptional activator. Genes Dev 4:1753-1765, 1990.
141. Veals SA, Schindler C, Leonard D, et al: Subunit of an alpha-interferon-responsive transcription factor is related to interferon regulatory factor and Myb families of DNA-binding proteins. Mol Cell Biol 12:3315-3324, 1992.
142. Fu X-Y, Schindler C, Improta T, et al: The proteins of ISGF-3, the interferon α-induced transcriptional activator, define a gene family involved in signal transduction. Proc Natl Acad Sci USA 90:7840-7843, 1992.
143. Schindler C, Fu X-Y, Improta T, et al: Proteins of a transcription factor ISGF-3: One gene encodes the 91- and 84-kDa ISGF-3 proteins that are activated by inteferon. Proc Natl Acad Sci USA 90:7836-7839, 1992b.
144. Driggers P, Ennist D, Gleason S, et al: An interferon-γ regulated protein that binds the interferon-inducible enhancer element of major histoconipatibility complex class I genes. Proc Natl Acad Sci USA 87:3743-3747, 1991.
145. Veals SA, Maria TS, Levy DE: Two domains of ISGF3 that mediate protein-DNA and protein-protein interacting during transcriptional factor assembly contribute to DNA-binding specificity. Mol Cell Biol 13:196-206, 1993.
146. Nelson N, Marks MS, Driggers PH, et al: Interferon consensus sequence-binding protein, a member of interferon regulatory factor family, suppresses interferon-induced gene transcription. Mol Cell Biol 13:588-599, 1993.
147. Muller M, Laxton C, Briscoe J, et al: Complementation of a mutant cell line: Central role of the 91 kDa polypeptide of ISGF3 in the interferon-α and -γ signal transduction pathways. EMBO J 11: 4221-4228, 1993.
148. Shuai K, Schindler C, Prezioso Vr, et al: Activation of transcription of IFN-γ: Tyrosine phosphorylation of a 91-kDa DNA binding protein. Science 258:1808-1812, 1992.
149. Shuai K, Stark GR, Kerr IM, et al: A single phosphotyrosine residue of Stat91 required for gene activation by interferon-γ. Science 261:1744-1746, 1993.
150. Wathelet MG, Clauss IM, Paillard F, et al: 2-Aminopurine selectively blocks the transcriptional activation of cellular genes by virus, double-stranded RNA and interferons in human cells. Eur J Biochem 184:503-509, 1989.
151. WatheletMG, Berr PM, Huez GA: Regulation of gene expression by cytokines and virus in human cells lacking the type I interferon locus. Eur J Biochem 206:901-910, 1992.
152. Bourgeade MF, Laurent-Winter C, Besancon F, et al: Differential kinetics of polypeptide expression and different biological activities in the human fibroblasts response to dsRNA or interferon treatment. J Interferon Res 13:175-186, 1993.
153. Yan C, Tamm I: Protein factors that bind to the murine 2′,5′-oligoadenylate synthetase ME-12 gene 5′ upstream regulatory region. J Biol Chem 265:29188-20194, 1990.
154. Yan C, Tamm I: Molecular cloning and characterization of interferon α/β response element binding factors of the murine 2′-5′ oligoadenylate synthetase ME-12 gene. Proc Natl Acad Sci USA 88:144-148, 1991.
155. Yan C, Tamm I: Molecular cloning and characterization of additional factors that bind to the interferon-α/β response element B of the murine 2′-5′ oligoadenylate synthetase ME-12 gene. Proc Natl Acad Sci USA 89:8859-8863, 1992.
156. Kumar A, Rutherford M, Haque S, et al: Proto-oncogene ETS-1 specifically binds the ISRE of 2-5A synthetase. J Interferon Res 11:S152, 1991.
157. Haque S, Kumar A, Fischer T, et al: Trans-repression of the IFN-response by transient expression of IBF-1, and ISRE-binding protein. J Interferon Res 11:S97, 1991.
158. Tiwari RK, Kusari J, Sen GC: Functional equivalents of interferon-mediated signals needed for induction of an mRNA can be generated by double-stranded RNA and growth factors. EMBO J 6:3373-3378, 1987.
159. Mundschau L, Faller D: BALB/C-3T3 fibroblasts resistant to growth inhibition by beta interferon exhibit aberrant platelet-derived growth factor, epidermal growth factor, and fibroblast growth factor signal transduction. Mol Cell Biol 11:3148-3154, 1991.
160. Garcia-Blanco M, Lengyel P, Morrison E, et al: Regulation of 2′-5′ oligoadenylate synthetase gene expression by interferons and platelet-derived growth factor. Mol Cell Biol 9:1060-1068, 1989.
161. Ruff-Jamison S, Chen K, Cohen S: Induction by EGF and interferon-γ of tyrosine phosphorylated DNA binding proteins in mouse liver nuclei. Science 261:1733-1736, 1993.
162. Lutticken C, Wegenka UM, Yuan J, et al: Association of transcription factor APRF and protein kinase JAK1 with the interleukin-6 signal transducer gp130. Science 263:89-92, 1994.
163. Stahl N, BoultonTG, Farruggella T, et al: Association and activation of JAK-tyk kinases by CNTF-LDR-OSM-IL-6 receptor components. Science 263:92-95, 1994.
164. Ho ASY, Liu Y, Khan TA, et al: A receptor for interleukin-10 is related to interferon receptors. Proc Natl Acad Sci USA 90:11267-11271, 1993.
165. Argetsinger LS, Campbell GS, Yang X, et al: Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase. Cell 74:237-244, 1993.
166. Witthuhn BA, Quelle FW, Silvennoinen O, et al: JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell 74: 227-236, 1993.
167. Meyer DJ, Campbell GS, Cochran BH, et al: Growth hormone induces a DNA binding factor related to the interferon-stimulated 91-kDa transcription factor. J Biol Chem 269:4701-4704, 1994.
168. Fox HS, Bond BL, Parslow TG: Estrogen regulates the IFN-γ promoter. J Immunol 146:4362-4367, 1991.
169. Rui H, Kirken RA, Farrar WL. Activation of receptor-associated tyrosine kinase JAK2 by prolactin. J Biol Chem 269:5364-5368, 1994.
170. Tanaka N, Kawakami T,Taniguchi T: Recognition DNA sequences of Interferon regulatory factor 1 (IRF-1) and IRF-2, regulators of cell growth and the interferon system. Mol Cell Biol 13:4531-4538, 1993.
171. Ackrill A, Reid L, Gilbert C, et al: Differential response of the human 6-16 and 9-27 genes to α and γ interferons. Nucleic Acid Res 19:591-598, 1991.
172. Caplan H, Gupta S: Differential regulation of a cellular gene by human interferon-γ and interferon-α. J Biol Chem 263:332-339, 1988.
173. Staeheli P: Interferon-induced proteins and the antiviral state. Adv Virus Res 38:147-199, 1990.
174. Hovanessian AG: The double-stranded RNA-activated protein kinase induced by interferon: dsRNA-PK. J Interferon Res 9:641-647, 1989.
175. Hovanessian A: Interferon-induced and double-stranded RNA-activated enzymes: A specific protein kinase and 2′-5′ oligoadenylate synthetases. J Interferon Res 11:199-205, 1991.
176. Clemens MJ, Hershey JW, Hovanessian AC, et al: PKR: Proposed nomenclature for the RNA dependent protein kinase induced by interferon. J Interferon Res 13:241, 1993.
177. Hovanessian A, Galabru, J: The double-stranded RNA-dependent protein kinase is also activated by heparin. Eur J Biochem 167:467-473, 1987.
178. Chen J-J, Throop MS, Gehrke L, et al: Cloning of the cDNA of the heme-regulated eukaryotic initiation factor 2α (eIF-2α) kinase of rabbit reticulocytes: Homology to yeast GCN2 protein kinase and human double-stranded-RNA-dependent eIF-2α kinase. Proc Natl Acad Sci USA 88:7729-7733, 1991.
179. Hershey JW: Translational control in mammalian cells. Annu Rev Biochem 60:717-55, 1991.
180. Black T, Safer B, Hovanessian A, et al: The cellular 68,000-Mr protein kinase is highly autophosphorylated and activated yet significantly degraded during poliovirus infection: Implications for translational regulation. J Virol 63:2244-2251, 1989.
181. Meurs E, Chong K, Galabru J, et al: Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell 62:379-390, 1990.
182. Katze MG, Wambach M, Wong M-L, et al: Functional expression and RNA binding analysis of the interferon-induced, double-stranded RNA activated, 68,000-Mr protein kinase in a cell-free system. Mol Cell Biol 11:5497-5505, 1991.
183. Feng GS, Chong K, Kumar A, et al: Identification of double-stranded RNA-binding domains in the interferon-induced double-stranded RNA-activated p68 kinase. Proc Natl Acad Sci USA 89:5447-5451, 1992.
184. Patel RC, Sen GC: Identification of the double stranded RNA-binding domain of the human interferon-inducible protein kinase. J Biol Chem 267:7671-7676, 1992.
185. Meurs EF, Watanabe Y, Kadereit S, et al: Constitutive expression of human double-stranded RNA-activated p68 kinase in murine cells mediates phosphorylation of eukaryotic initiation factor 2 and partial resistance to encephalomyocarditis virus growth. J Virol 66:5804-5814, 1992.
186. Koromilas AE, Roy S, Barber GN, et al: Malignant transformation by a mutant of the IFN-inducible dsRNA dependent protein kinase. Science 257:1685-1689, 1992.
187. Meurs EF, Galabru J, Barber GN, et al: Tumor suppressor function of the interferon-induced double-stranded RNA-activated protein kinase. Proc Natl Acad Sci USA 90:232-236, 1993.
188. Chong KL, Feng L, Schappert K, et al: Human p68 kinase exhibits growth suppression in yeast and homology to the translational regulator GCN2. EMBO J 11:1553-1562, 1992.
189. Kalvakolanu DVR, Bandyopadhyay SK, Tiwari RK, et al: Enhancement of expression of exogenous genes by 2-aminopurine: Regulation at the post transcriptional level. J Biol Chem 266:873-879, 1991.
190. Petryshyn R, Chen JJ, London IM: Detection of activated double-stranded RNA-dependent protein kinase in 3T3-F442A cells. Proc Natl Acad Sci USA 85:1427-1431, 1988.
191. Farrel P, Balkow K, Hunt T, et al: Phosphorylation of initiation factor eIF-2 and the control of reticulocyte protein synthesis. Cell 11:187-200, 1977.
192. Choi S-Y, Scherer BJ, Schnier J, et al: Stimulation of protein synthesis in COS cells transfected with variants of the α-subunit of initiation factor eIF-2. J Biol Chem 267:286-293, 1992.
193. Zinn K, Keller A, Whittemore LA, et al: 2-Aminopurine selectively inhibits the induction of β-interferon, c-fos, and c-myc gene expression. Science 240:210-213, 1988.
194. Kumar A, Haque J, Lacoste J, et al: Double stranded RNA-dependent protein kinase activates transcription factor NF-κB by phosphorylating IκB. Proc Natl Acad Sci USA 91:6288-6292, 1994.
195. Williams B, Silverman R, eds: The 2-5A System: Clinical and Molecular Aspects of the Interferon Regulated Pathway, New York, Alan R. Liss, 1985.
196. Saunders M, Gewert D, Tugwell M, et al: Human 2-5A synthetase: Characterization of a novel cDNA and corresponding gene structure. EMBO J 4:1761-1768, 1985.
197. Chebath J, Benech P, Hovanessian A, et al: Four different forms of interferon-induced 2′-5′oligo(A) synthetase identified by immunoblotting in human cells. J Biol Chem 262:3852-3857, 1987.
198. Ghosh S, Kusan J, Bandyopadhyay S, et al: Cloning, sequencing, and expression of two murine 2′-5′-oligoadenylate synthetases. J Biol Chem 266:15293-15299, 1991.
199. Merlin G, Chebath J, Benech P, et al: Molecular cloning and sequence of partial cDNA for interferon-induced (2′-5′) oligo(A) synthetase mRNA from human cells. Proc Natl Acad Sci USA 80:4904-4908, 1983.
200. St Laurent G, Yoshie O, Floyd-Smith G, et al: Interferon action: Two (2′-5′)(A)n synthetases specified by distinct mRNAs in Ehrlich ascites tumor cells treated with Interferon. Cell 33:95-102, 1983.
201. Marie I, Svab J, Robst N, et al: Differential expression and distinct structure of 69- and 100-kDa forms of 2-5A synthetase inhuman cells treated with interferon. J Biol Chem 265:18601-18607, 1990.
202. Marie I, Hovanessian AG: The 69-kDa 2-5A synthetase is composed of two homologous and adjacent functional domains. J Biol Chem 267:9933-9939, 1992.
203. Hovanessian A, Svab J, Marie I, et al: Characterization of 69- and 100-kDa forms of 2-5A synthetase from interferon-treated human cells. J Biol Chem 263:4959-4969, 1988.
204. Marie I, Svab J, Hovanessian A: The binding of the 69- and 100-kD forms of 2′,5′-oligoadenylate synthetase to different polymicleotides. J Interferon Res 10:571-578, 1990.
205. Silverman RH, Krause D, Jacobsen H, et al: 2-5A dependent RNase levels vary with interferon treatment, growth rate and cell differentiation. In: The Biology of Interferon System, edited by E DeMaeyer, H Schellekens, Amsterdam, Elesevier, 1983, pp 189-200.
206. Krause D, Silverman RH, Jacobsen H, et al: Regulation of ppp(A2′p)n-dependent RNase levels during interferon treatment and cell differentiation. Eur J Biochem 146:611-618, 1985.
207. Hassel BA, Zhou A, Sotomayor C, et al: A dominant negative mutant of 2-5A-dependent RNase suppresses antiproliferative and antiviral effects of interferon. EMBO J 12:3297-3304, 1993.
208. Chebeth J, Benech P, Revel M, et al: Constitutive expression of (2′-5′) oligo A synthetase confers resistance to picornavirus infection. Nature 330:587-588, 1987.
209. Rysiecki G, Gewart D, Williams B: Constitutive expression of a 2′-5′-oligoadenylate synthetase cDNA results in increased antiviral activity and growth suppression. J Interferon Res 9:649-657, 1990.
210. + cells against human immunodeficiency virus (HIV) infection after stable transfection with HIV LTR-2′,5′-oligoadenylate synthetase hybrid gene. FASEB 14:3124-3130, 1990.
211. Sperling J, Chebath J, Arad-Dann H, et al: Possible involvement of (2′-5′)oligoadenylate synthetase activity in pre-mRNA splicing. Proc Natl Acad Sci USA 88:10377-10381, 1991.
212. Kumar R, Mendelsohn J: Role of 2′-5′-oligoadenylate synthetase in γ-interferon-mediated growth inhibition of A431 cells. Cancer Res 49:5180-5184, 1989.
213. Constantoulakis P, Campbell M, Felber BK, et al: Inhibition of Rev-mediated HIV-1 expression by an RNA binding protein encoded by the interferon-inducible 9-27 gene. Science 259:1314-1318, 1993.
214. Staeheli P, Haller O, Boll W, et al: Mx protein: Constitutive expression in 3T3 cells transformed with cloned Mx cDNA confers selective resistance to influenza virus. Cell 44:147-158, 1986.
215. Arnheiter H, Haller O: Antiviral state against influenza virus neutralized by microinjection of antibodies to interferon-induced Mx proteins. EMBO J 7:315-1320, 1988.
216. Arnheiter H, Skuntz S, Noteborn M, et al: Transgenic mice with intracellular immunity to influenza virus. Cell 62:51-61, 1990.
217. Arnheiter H, Meier E: Mx proteins: Antiviral by chance or by necessity? New Biol 2:851-857, 1990.
218. Krug R, Shaw M, Broni B, et al: Inhibition of influenza virus messenger RNA synthesis in cells expressing the interferon-induced Mx gene product. J Virol 56:201-206, 1985.
219. Huang T, Pavlovic J, Staeheli P, et al: Overexpression of the influenza virus polymerase can titrate out inhibition by the murine Mx1 protein. J Virol 66:4154-4160, 1992.
220. Pavlovic J, Zurcher T, Haller O, et al: Resistance to influenza and vesicular stomatitis virus conferred by expression of human MxA protein. J Virol 64:3370-3375, 1990.
221. Staeheli P and Pavlovic J: Inhibition of vesicular stomatitis virus mRNA synthesis by human MxA protein. J Virol 65:4498-4501, 1991.
222. Zurcher T, Pavlovic J, Staeheli P: Mechanism of human Mx A protein action: Variants with changed antiviral properties. EMBO J 11:1657-1661, 1992.
223. Pavlovic J, Haller O, Staeheli P: Human and mouse Mx proteins inhibit different steps of the influenza virus multiplication cycle. J Virol 66:2564-2569, 1992.
224. Pitossi F, Blank A, Schroder A, et al: A functional GTP-binding motif is necessary for antiviral activity of Mx proteins. J Virol 67:6726-6732, 1993.
225. Rothman J, Raymond C, Gilbert T, et al: A putative GTP binding protein homologous to interferon-inducible Mx proteins performs an essential function in yeast protein sorting. Cell 61:1063-1074, 1990.
226. Obar R, Collins C, Hammarback J, et al: Molecular cloning of the microtubule-associated mechanochemical enzyme dynamin reveals homology with a new family of GTP-binding proteins. Nature 347:256-261, 1990.
227. Pfefferkorn ER: Interferon-gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. Proc Natl Acad Sci USA 81:908-912, 1984.
228. Carlin JM, Borden EC, Sondel PM, et al: Interferon-induced indoleamine 2,3-dioxygenase activity in human mononuclear phagocytes. J Leuk Biol 45:29-34, 1989.
229. Takikawa O, Kuroiwa T, Yamazaki F, et al: Mechanisms of interferon-gamma action: Characterization of indoleamine 2,3-dioxygenase in cultured human cells induced by IFN gamma and evaluation of the enzyme-mediated tryptophan degradation in its anticellular activity. J Biol Chem 263:2041-2048, 1988.
230. Werner ER, Werner-Felmayer G, Fuchs D, et al: Parallel induction of tetrahydrobiopterin biosynthesis and indoleamine 2,3-dioxygenase activity in human cells and cell lines by interferon-gamma. Biochem J 262:861-866, 1989.
231. Ozaki Y, Edelstein MP, Duch DS: Induction of indoleamine 2,3-dioxygenase: A mechanism of the antitumor activity of IFN-gamma. Proc Natl Acad Sci USA 85:1242-1246, 1988.
232. Carlin JM, Borden EC, Byrne GI: Enhancement of indoleamine 2,3-dioxygenase activity in cancer patients receiving interferon-betaser. J Interferon Res 9:167-173, 1989.
233. Pfefferkorn ER, Eckel M, Rebhun S: Interferon-gamma suppresses the growth of Toxoplasma gondii in human fibroblasts through starvation for tryptophan. Mol Biochem Parasitol 20:215-224, 1986.
234. Byrne GI, Lehmann LK, Landry GJ: Induction of tryptophan catabolism is the mechanism for gamma-interferon-mediated inhibition of intracellular Chlamydia psittaci replication in T24 cells. Infect Immun 53:344-351, 1986.
235. de la Maza LM, Peterson EM: Dependence on the in vitro antiproliferative activity of recombinant human ã-interferon on the concentration of tryptophan in culture media. Cancer Res 48:346-350, 1988.
236. Carlin JM, Oxaki Y, Byrne GI, et al: Interferons and indoleamine 2,3-dioxygenase: Role in antimicrobial and antitumor effects. Experientia 45:535-541, 1989.
237. Yoshida R, Park SW, Yasui H, et al: Tryptophan degradation in transplanted tumor cells undergoing rejection. J Immunol 141:2819-2823, 1988.
238. Wooley PV III, Dion RL, Bono VH Jr.: Effects of tryptophan deprivation on L1210 cells in culture. Cancer Res 34:1010-1014, 1974.
239. Roberts J, Schmid FA, Rosenfeld HJ: Biologic and antineoplastic effects of enzyme-mediated in vivo depletion of L-glutamine, L-tryptophan, and L-histidine. Cancer Treat Rep 63:1045-1054, 1979.
240. Clemens JM, Tilleray VJ, James R, et al: Relationship of cellular oncogene expression to inhibition of growth and induction of differentiation of Daudi cells by interferons or TPA. J Cell Biochem 38:251-259, 1988.
241. Jonak GJ, Knight E, Jr.: Selective reduction of c-myc RNA in Daudi cells by human beta interferon. Proc Natl Acad Sci USA 81:1747-1750, 1984.
242. Kimchi A: Autocrine interferon and the suppression of the c-myc oncogene. Interferon 8:87-110, 1987.
243. Resnitzky D, Yarden A, Zipori D, Kimchi A: Autocrine beta-related interferon controls c-myc suppression and growth arrest during hematopoietic cell differentiation. Cell 46:31-40, 1993.
244. Gonda TJ, Metcalf D: Expression of myb, myc and fos protooncogenes during the differentiation of a murine myeloid leukaemia. Nature 310:249-251, 1984.
245. Einat M, Resnitzky D, Kimchi A: Inhibitory effects of interferon on the expression of genes regulated by platelet-derived growth factor. Proc Natl Acad Sci USA 82:7608-7612, 1985.
246. Marth C, Cronauer MV, Doppler W, Ofner D, Ullrich A, Daxenbichler G: Effects of interferons on the expression of the proto-oncogene her-2 in human ovarian carcinoma cells. Int J Cancer 50:64-68, 1992.
247. Souslau G, Bogucki AR, Gillespie D, Hubbell HR: Phosphoproteins altered by antiproliferative doses of human interferon-beta in a human bladder carcinoma cell line. Biochem Biophys Res Commun 119:941-948, 1984.
248. Samid D, Flessate DM, Greene JJ, Chang EH, Friedman RM: Persisting revertants after interferon treatment of oncogene-transformed cells. In: The Biology of the Interferon System edited by WE Stewart II, H Schellekens, Amsterdam, Elsevier, 1984, pp 327-332.
249. SIC and expression of the transformation-related phenotype in interferon-treated Rous sarcoma virus-transformed rat cells. Mol Cell Biol 3:1656-1664, 1983.
250. Samid D, Chang FH, Friedman RM: Biochemical and biophysical correlates of phenotypic reversion in interferon-treated mouse cells transformed by a human oncogene. Biochem Biophys Res Commun 119:21-28, 1984.
251. Soslau G, Bogucki AR, Gillespie D, Hubbell HR: Phosphoproteins altered by antiproliferative doses of human interferon-beta in a human bladder carcinoma cell line. Biochem Biophys Res Commun 119:941-948, 1984.
252. Contente S, Kenyon K, Rimoldi D, Friedman RM: Expression of gene rrg is associated with reversion of NIH 3T3 transformed by LTR-c-H-ros. Science 249:796-798, 1990.
253. Brouty-Boye D, Gresser I: Reversibility of the transformed and neoplastic phenotype. I. Progressive reversion of the phenotype of X-ray transformed C3H/10T1/2 cells under prolonged treatment with interferon. Int J Cancer 28:165-173, 1981.
254. Sergiescu D, Gerfaux J, JoretAM, Chany C: Persistent expression of v-mos oncogene in transformed cells that revert to nonmalignancy after prolonged treatment with interferon. Proc Natl Acad Sci USA 83:5764-5768, 1986.
255. Levine AJ: The tumor suppressor genes. Annu Rev Biochem 62:623-651, 1993.
256. Squire J, Meurs EF, Chong KL, et al: Localization of the human interferon-induced, ds-RNA activated p68 kinase gene (PKR) to chromosome 2p21-p22. Genomics 16:768-770, 1993.
257. Lengyel PL: Tumor-suppressor genes: News about the interferon connection. Proc Natl Acad Sci USA 90:5893-5895, 1993.
258. Kitajewski J, Schneider R, Safer B, et al: Adenovirus VAI RNA antagonizes the antiviral action of interferon by preventing activation of the interferon-induced eIF-2α kinase. Cell 45:195-200, 1986.
259. Galabru J, Katze M, Robert N, et al: The binding of double-stranded RNA and adenovirus VAIRNA to the interferon-induced protein kinase. Eur J Biochem 178:581, 1989.
260. Davies MV, Furtado M, Hershey JWB, et al: Complementation of adenovirus-associated RNA I gene deletion by expression of a mutant eukaryotic translation initiation factor. Proc Natl Acad Sci USA 86:9163-9167, 1989.
261. Mathews M, Shenk T: Adenovirus virus-associated RNA and translation control. J Virol 65:5657-5662, 1991.
262. Ghadge G, Swaminathan S, Katze M, et al: Binding of the adenovirus VAI RNA to the interferon-induced 68-kDa protein kinase correlates with function. Proc Natl Acad Sci USA 88:7140-7144, 1991.
263. Roy S, Katze M, Parkin N, et al: Control of the interferon-induced 68-kilodalton protein kinase by the HIV-1 tat gene product. Science 247:1216-1219, 1990.
264. Imani F, Jacobs, B: Inhibitory activity for the interferon-induced protein kinase is associated with the reovirus serotype 1 σ3 protein. Proc Natl Acad Sci USA 85:7887-7891, 1988.
265. Lee T, Tomita J, Hovanessian A, et al: Purification and partial characterization of a cellular inhibitor of the interferon-induced protein kinase of Mr 68,000 from influenza virus-infected cells. Proc Natl Acad Sci USA 87:6208-6212, 1990.
266. BeattieE, Tartagglial, PoalettiE: Vaccinia virus-encoded eIF-2α homolog abrogates the antiviral effect of interferon. Virology 183:419-422, 1991.
267. Davies MV, Elroy-Stein O, Jagus R, et al: The vaccinia virus K3L gene product potentiates translation by inhibiting double-stranded-RNA-activated protein kinase and phosphorylation of the alpha subunit of eukaryotic initiation factor 2. J Virol 1943-1950, 1992.
268. Chang H-W, Watson JC, Jacobs BL: The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase. Proc Natl Acad Sci USA 89:4825-4829, 1992.
269. Akkaraju G, Whitaker-Dowling P, Youngner J, et al: Vaccinia specific kinase inhibitory factor prevents translational inhibition by double-stranded RNA in rabbit reticulocyte lysate. J Biol Chem 264:10321-10325, 1989.
270. Higashi Y, Sokawa Y: Microinjection of interferon and 2′-5′-oligoadenylate into mouse L cells and their effects on virus growth. J Biol Chem 91:2021-2028, 1982.
271. Zhou A, Hassel BA, Silverman RH: Expression cloning of 2-5A-dependent RNAase: A uniquely regulated mediator of interferon action. Cell 72:753-765, 1993.
272. Cayley P, Davies J, McCullagh K, et al: Activation of the ppp(A2′p)nA system in interferon-treated, herpes simplex virus-infected cells and evidence for novel inhibitors of the ppp(A2′p)nA-dependent RNase. Eur J Biochem 143:165-174, 1984.
273. Harada H, Kitagawa M, Tanaka N, et al: Antioncogenic and oncogenic potentials of interferon regulatory factors-1 and -2. Science 259:971-974, 1993.
274. Willman CL, Sever CE, Pallavicini MG, et al: Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia. Science 259:968-971, 1993.
275. Anderson KP, Fennie EM: Adenovirus early region 1A modulation of interferon antiviral activity. J Virol 61:787-795, 1987
276. Reich N, Pine R, Levy D, et al: Transcription of interferon-stimulated genes is induced by adenovirus particles but is suppressed by E1A gene products. J Virol 62:114-119, 1988.
277. Shenk T, Flint J: Transcriptional and transforming activities of the adenovirus E1A proteins. Adv Cancer Res 57:47-85, 1991.
278. Ackrill AM, Foster GR, Laxton CD, et al: Inhibition of the cellular response to interferons by products of the adenovirus type 5 E1A oncogene. Nucleic Acids Res 20:1531-1538, 1991.
279. Gutch MJ, Reich NC. Repression of the interferon signal transduction pathway by the adenovirus E1A oncogene. Proc Natl Acad Sci USA 88:7913-7917, 1991.
280. Kalvakolanu DV, Bandyopadhyay SK, Harter ML, et al: Inhibition of interferon-inducible gene expression by adenovirus E1A proteins: Block in transcriptional complex formation. Proc Natl Acad Sci USA 88:7459-7463, 1991.
281. Imperiale MJ, Kao H-T, Feldman LT, et al: Common control of the heat shock gene and early adenovirus genes: Evidence for a cellular E1 A-like activity. Mol Cell Biol 4:867-874, 1984.
282. Kalvakolanu DVR, Sen GC: Differentiation-dependent activation of interferon-stimulated gene factors and transcription factor NF-κB in mouse embryonal carcinoma cells. Proc Natl Acad Sci USA 90:3167-3171, 1993.
283. Suemori H, Hashimoto S, Nakatsuji N: Presence of the adenovirus E1A-like activity in preimplantation stage mouse embryos. Mol Cell Biol 8:3553-3555, 1988.
284. Jacyna MR, Thomas HC: Antiviral therapy: Hepatitis B. Br Med Bull 46:368-382, 1990.
285. Foster G, Ackrill A, Goldin R, et al: Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferons α and γ and double-stranded RNA. Proc Natl Acad Sci USA 88:2888-2892, 1991.
286. Kerr IM, Stark GR: The antiviral effects of the interferons and their inhibition. J Interferon Res 12:237-240, 1992.
287. Whitten TM, Quels AT, Schloemer RH: Identification of the hepatitis B virus factor that inhibits expression of the beta interferon gene. J Virol 65:4699-4704, 1991.
288. Straus SE, Cohen JI, Tosato G, et al: Epstein-Barr virus infections: Biology, pathogenesis, and management. Ann Intern Med 118:45-58, 1993.
289. Kanda K, Decker T, Aman P, et al: The EBNA-2 related resistance towards alpha interferon (IFN-alpha) in Burkitt's lymphoma cells effects induction of IFN-stimulated genes but not the activation of transcription factor ISGF-3. Mol Cell Biol 12:4930-4936, 1992.
290. Cohen JI, Picchio GR, Mosier DE: Epstein-Barr virus nuclear protein 2 is a critical determinant for tumor growth in SCID mice and for transformation in vitro. J Virol 66:7555-7559, 1992.
291. Sinclair AJ, Farrell PJ: Epstein-Barr virus transcription factors. Cell Growth Diff 3:557-563, 1992.
292. Buller RM, Palumbo GJ: Poxvirus pathogenesis. Microbiol Rev 55:80-122, 1991.
293. Kotwal GJ, Moss B: Vaccinia virus encodes a secretory polypeptide structurally related to complement control proteins. Nature 335:176-178, 1988.
294. Smith CA, Davis T, Anderson D, et al: A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 248:1019-1023, 1990.
295. Smith CA, Davis T, Wignall JM, et al: T2 open reading frame from the Shope fibroma virus encodes a soluble form of the TNF receptor. Biochem Biophys Res Commun 176:335-342, 1991.
296. Upton C, Mossman K, McFadden G: Encoding of a homolog of the IFN-γ receptor by myxoma virus. Science 258:1369-1372, 1992.
297. Williams BRG: Review: Transcriptional regulation of interferon-stimulated genes. Eur J Biochem 200:1-11, 1991.
298. Foon KA: Biological response modifiers: The new immunotherapy. Cancer Res 49:1621-1639, 1989.
299. Koller BH, Orr HT: Cloning and complete sequence of an HLA-A2 gene: Analysis of two HLA-A alleles at the nucleotide level. J Immunol 134:2727-2733, 1985.
300. Wu L-C, Morely BJ, Campbell RD: Cell specific expression of the human complement protein factor B gene: Evidence for the role of two distinct 5′-flanking elements. Cell 48:331-342, 1987.
301. Luster AD, Ravetch JV: Genomic characterization of a gamma-interferon-inducible gene (IP-10) and identification of an interferon-inducible hypersensitive site. Mol Cell Biol 7:3723-3731, 1987.
302. Chang KC, Hansen E, Foroni L, et al: Molecular and functional analysis of the virus and interferon-inducible human Mx A promoter. Arch Virol 117:1-15, 1991.
303. b promoter: Enhancer-like sequences and their role in the regulation of class I gene expression. Cell 44:261-272, 1986.
304. Korber B, Mermod N, Hood L, et al: Regulation of gene expression by interferon: Control of H2-promoter responses. Science 239:1302-1306, 1988.
305. Samanta H, Engel D, Chao H, et al: Interferons as gene activators: Cloning of the 5′ terminus and the control segment of an interferon activated gene. J Biol Chem 261:11849-11858, 1986.
306. Strehlow I, Seegert D, Frick C, et al: The gene encoding IFP 53/tryptophanyl-tRNA synthetase is regulated by gamma-interferon activation factor. J Biol Chem 268:16590-16595, 1993.
307. Wright TM, Farber JM: 5′ regulatory region of a novel cytokine gene mediates selective activation by interferon gamma. J Exp Med 173:417-422, 1991.
308. Reith W, Barras E, Satola S, et al: Cloning of the major histocompatibility complex class II promoter binding protein affected in a hereditary defect in class II gene regulation. Proc Natl Acad Sci USA 86:4200-4204, 1989.
309. Reith W, Herero-Sanchez C, Kobr M, et al: MHC class II regulatory factor RFX has novel DNA-binding domain and a functionally independent dimerization domain. Genes Dev 4:1528-1540, 1990.
310. Liou H-C, Boothby MR, Finn PW, et al: A new member of the leucine zipper class of proteins that binds to the HLA DR-alpha promoter. Science 247:1581-1584, 1990.
311. Ono SJ, Liou HC, Davidon R, et al: Human X-box-binding protein 1 is required for the transcription of a subset of human class II major histocompatibility genes and forms a heterodimer with c-fos. Proc Natl Acad Sci USA 88:4309-4312, 1991.
312. Ono S, Bazil V, Levi B-Z, et al: Transcription of a subset of human class II major histocompatibility complex genes is regulated by a nucleoprotein complex that contains c-fos or an antigenically related protein. Proc Natl Acad Sci USA 88:4304-4308, 1991.
313. Kieran M, Blank V, Logeat F, et al: The DNA binding subunit of NF-κB is identical to factor KBF1 and homologous to the rel oncogene product. Cell 62:1007-1018, 1990.
314. Wallach D, Fellous M, Revel M: Preferential effect of γ-interferon on the synthesis of HLA antigens and their mRNAs in human cells. Nature 299:834-836, 1982.
315. Chebath J, Merlin G, Metz R, et al: Interferon-induced 56,000 Mr protein and its mRNA in human cells: Molecular cloning and partial sequences of the cDNA. Nucleic Acids Res 11:1213-1226, 1983.
316. Vanguri P, Farber JM: Identification of CRG-2: An interferon-inducible mRNA predicted to encode a murine monokine. J Biol Chem 265:15049-15057, 1990.
317. Shan B, Vazquez E, Lewis JA: Interferon selectively inhibits the expression of mitochondrial genes: A novel pathway for interferon-mediated responses. EMBO J 9.4307-4314, 1990.
318. Stuehr D, Marletta M: Induction of nitrite/nitrate synthesis in murine macrophages by BCG infection, lymphokines or interferon-γ. J Immunol 139:518-525, 1987.
319. Stuehr D, Cho H, Kwon N, et al: Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: An FAD- and FMN-containing flavoprotein. Proc Natl Acad Sci USA 88:7773-7777, 1991.
320. Levy DE, Lamer AC, Chaudhuri A, et al: Interferon-stimulated transcription: Isolation of an inducible gene and identification of its regulatory region. Proc Natl Acad Sci USA 83:8929-8933, 1986.
321. Cassatella M, Bazzoni F, Calzetti F, et al: Interferon-γ transcriptionally modulates the expression of the genes for the high affinity IgG-Fc receptor and the 47-kDa cytosolic component of NADPH oxidase in human plymorphonuclear leukocytes. J Biol Chem 266:22079-22082, 1991.
322. Staeheli P, Prochazka M, Steigmeier P, Haller O: Genetic control of interferon action: Mouse strain distribution an inheritance of an induced protein with guanylate-binding property. Virology 137:135-142, 1984.
323. Cheng Y, Becker-Manley M, Chow T, et al: Affinity purification of an interferon-induced human guanylate-binding protein and its characterization. J Biol Chem 260:15834-15839, 1985.
324. Margolis-Nunno H, Rubin B, Anderson S, et al: Isolation of cDNA clones for the interferon-induced 67,000 dalton protein: Direct induction of a family of mRNAs by interferon-α and by interferon-γ. J Interferon Res 10:309-319, 1990.
325. Rubin BY, Anderson SL, Hellerman GR, et al: The development of antibody to the interferon-induced indoleamine 2,3-dioxygenase and the study of the regulation of its synthesis. J Interferon Res 8:691-702, 1988.
326. Haas A, Ahrens P, Bright P, et al: Interferon induces a 15-kilodalton protein exhibiting marked homology to ubiquitin. J Biol Chem 262:11315-11323, 1987.
327. Bange C-F, Vogel U, Flohr T, et al: IFP 35 is an interferon-α induced leucine zipper protein that undergoes interferon-regulated cellular redistribution. J Biol Chem 269:1091-1098, 1994.
328. Barr CL, Saunders GF: Interferon-γ-inducible regulation of the human invariant chain gene. J Biol Chem 266:3475-3481, 1991.
329. Luster A, Unkeless J, Ravetch J: γ-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins. Nature 315:672-676, 1985.
330. Luster A, Weinshank R, Feinman R, et al: Molecular and biochemical characterization of a novel γ-interferon-inducible protein. J Biol Chem 263:12036-12043, 1988.
331. Miyamoto M, Fijita T, Kimura Y, et al: Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-gene regulatory elements. Cell 54:903-913, 1988.
332. Harris CA, Hunte B, Krauss MR, et al: Induction of leucine aminopeptidase by interferon-gamma: Identification byprotein microsequencing after purification by preparative two-dimensional gel electrophoresis. J Biol Chem 267:6865-6869, 1992.
333. Harris CA, Derbin KS, Hunte-McDonough B, et al: Manganese superoxide dismutase is induced by DRN-gamma in multiple cell types: Synergistic induction by IFN-gamma and tumor necrosis factor or IL-1. J Immunol 147:149-154, 1991.
334. Rubin B, Anderson S, Xing L, et al: Interferon induces typtophanyl tRNA synthetase expression in human fibroblasts. J Biol Chem 266:24245-24248, 1991.
335. Rosa FM, Fellous M: Regulation of HLA-DR gene by IFN-gamma: Transcriptional and post- transcriptional control. J Immunol 140:1660-1664, 1988.
336. Newburger P, Ezekkowitz R, Whitney C, et al: Induction of phagocyte cytochrome b heavy chain gene expression by interferon γ. Proc Natl Acad Sci USA 85:5215-5219, 1988.
337. Robertson M: Antigen processing: Pioteasomes in the pathway. Nature 353:300-301, 1991.
338. Parham P: Antigen processing: Transporters of delight. Nature 348:674-675, 1990.
339. Fan X, Stark G, Bloom B: Molecular cloning of a gene selectively induced by gamma interferon from human macrophage line U937. Mol Cell Biol 9:1922-1928, 1989.
340. Choubey D, Snoddy J, Chaturvedi V, et al: Interferons as gene activators: Indications for repeated gene duplication during the evolution of a cluster of interferon-activatable genes on murine chromosome. J Biol Chem 264:17182-17189, 1989.
341. Katze M, DeCorato D, Safer B, et al: Adenovirus VA1 RNA complexes with the 68000 Mr protein kinase to regulate its autophosphorylation and activity. EMBO J 6:689-687, 1988.
342. Clarke P, Schwemmle M, Schickinger J, et al: Binding of Epstein-Barr virus small RNA EBER-1 to the double-stranded RNA-activated protein kinase DAI. Nucleic Acids Res 19:243-248, 1991.
343. Judware R, Li J, Petryshyn R: Inhibition of the dsRNA-dependent protein kinase by a peptide derived from the human immunodeficiency virus type 1 Tat protein. J Interferon Res 13:153-160, 1993.
344. KatzeM, Tomita J, Black T, et al: Influenza virus regulates protein synthesis during infection by repressing autophosphorylation and activity of the cellular 68,000-Mr protein kinase. J Virol 62:3710-3717, 1988.
345. Darnell JE, Jr., Kerr IM, Stark GR: Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415-1421, 1994.
346. Schindler C, Darnell JE, Jr.: Transcriptional responses to polypeptide ligands: The JAK-STAT pathway. Ann Rev Biochem 64:621-651, 1995.
347. Mignoe T-S, Lin J-X, Cereseto A, et al: Constitutively activated Jak-STAT pathway in T-cells transformed with HTLV-I. Science 269:79-81, 1995.
348. Yu C-L, Meyer DJ, Campbell GS, et al: Enhanced DNA-binding of a Stat3-related protein in cells transformed by the Src oncoprotein. Science 269:81-83, 1995.